Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516232 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
ElectronicAdd to Basket
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Inflammatory Bowel Disease Therapeutics - Global Strategic Business Report

Global Industry Analysts, Inc., April 2010, Pages: 611


  Description  
   Table of Contents   
   Companies Mentioned   
    
    
     
  Enquire before Buying   
  Send to a Friend   

This report analyzes the Global market for Inflammatory Bowel Disease Therapeutics in US$ Million.

Annual estimates and forecasts are provided for the period 2006 through 2015.

The report profiles 69 companies including Abbott Laboratories, Biogen Idec, Inc., Cosmo Pharmaceuticals SpA, ChemoCentryx, Inc., Dr. Falk Pharma GmbH, Eisai Co., Ltd., Elan Corporation, plc, Ferring Pharmaceuticals A/S, GlaxoSmithKline plc, Johnson & Johnson, Centocor Ortho Biotech, Inc, Kyorin Pharmaceutical Co., Ltd., Merck Serono, Millennium Pharmaceuticals, Inc., Mitsubishi Tanabe Pharma Corporation, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Prometheus Laboratories, Inc., Shire plc, UCB SA, and Wyeth.

Market data and analytics are derived from primary and secondary research.

Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.

For information on site licence pricing please click on Enquire before buying



Customers who bought this item also bought

Pipeline Insight: Inflammatory Bowel Disease - Varied drug targets to broaden future therapy options

Anti-TNF Therapies in IBD: Opinion Leader Insight into Current & Future Treatment Practices

Gastrointestinal Disorder Therapeutics to 2016 - High Unmet Needs Triggering Strong Growth in Crohn's Disease and Irritable Bowel Syndrome Markets

Epidemiology: Inflammatory Bowel Disease

5-Aminosalicylate Therapies in IBD: Opinion Leader Insight into Current & Future Treatment Practices

Special Report: The Autoimmune Biologics Pipeline-A Competitive Review

Ulcerative Colitis: KOL Insights on Treatment Practices and Unmet Needs

Therapeutic Clinical Intelligence - Inflammatory Bowel Disease

Clinical Dilemmas in Inflammatory Bowel Disease: New Challenges, 2nd Edition

Global Ulcerative Colitis Drug Pipeline Capsule - 2012



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds